230 related articles for article (PubMed ID: 34098977)
1. Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation.
Yoon SM; Suh R; Abtin F; Moghanaki D; Genshaft S; Kamrava M; Drakaki A; Liu S; Venkat P; Lee A; Chang AJ
Radiat Oncol; 2021 Jun; 16(1):99. PubMed ID: 34098977
[TBL] [Abstract][Full Text] [Related]
2. Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical Trial.
Xiang L; Zhang JW; Lin S; Luo HQ; Wen QL; He LJ; Shang CL; Ren PR; Yang HR; Pang HW; Yang B; He HL; Chen Y; Wu JB
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1027-1034. PubMed ID: 26194678
[TBL] [Abstract][Full Text] [Related]
3. Interstitial single fraction brachytherapy for malignant pulmonary tumours.
Rashid A; Pinkawa M; Haddad H; Hermani H; Temming S; Schäfer A; Bischoff P; Kovács A
Strahlenther Onkol; 2021 May; 197(5):416-422. PubMed ID: 33725134
[TBL] [Abstract][Full Text] [Related]
4. Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors.
Nguyen KNB; Hause DJ; Novak J; Monjazeb AM; Daly ME
Pract Radiat Oncol; 2019 Mar; 9(2):e196-e202. PubMed ID: 30496842
[TBL] [Abstract][Full Text] [Related]
5. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
6. Treatment of metastatic, imatinib refractory, gastrointestinal stroma tumor with image-guided high-dose-rate interstitial brachytherapy.
Omari J; Drewes R; Matthias M; Mohnike K; Seidensticker M; Seidensticker R; Streitparth T; Ricke J; Powerski M; Pech M
Brachytherapy; 2019; 18(1):63-70. PubMed ID: 30385116
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes and patterns of radiologic appearance after hypofractionated image-guided radiotherapy delivered with helical tomotherapy (HHT) for lung tumours.
Arcangeli S; Falcinelli L; Bracci S; Greco A; Monaco A; Dognini J; Chiostrini C; Bellavita R; Aristei C; Donato V
Br J Radiol; 2017 Mar; 90(1071):20160853. PubMed ID: 28256158
[TBL] [Abstract][Full Text] [Related]
8. CT-guided interstitial single-fraction brachytherapy of lung tumors: phase I results of a novel technique.
Ricke J; Wust P; Wieners G; Hengst S; Pech M; Lopez Hänninen E; Felix R
Chest; 2005 Jun; 127(6):2237-42. PubMed ID: 15947343
[TBL] [Abstract][Full Text] [Related]
9. CT-guided interstitial brachytherapy of inoperable non-small cell lung cancer.
Wang ZM; Lu J; Liu T; Chen KM; Huang G; Liu FJ
Lung Cancer; 2011 Nov; 74(2):253-7. PubMed ID: 21513997
[TBL] [Abstract][Full Text] [Related]
10. Computed tomography-guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies.
Tselis N; Ferentinos K; Kolotas C; Schirren J; Baltas D; Antonakakis A; Ackermann H; Zamboglou N
J Thorac Oncol; 2011 Mar; 6(3):545-52. PubMed ID: 21258257
[TBL] [Abstract][Full Text] [Related]
11. Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.
Mesko S; Swamy U; Park SJ; Borja L; Wang J; Demanes DJ; Kamrava M
Brachytherapy; 2015; 14(5):626-32. PubMed ID: 26024784
[TBL] [Abstract][Full Text] [Related]
12. Image-guided interstitial high-dose-rate brachytherapy for dose escalation in the radiotherapy treatment of locally advanced lung cancer: A single-institute experience.
Chatzikonstantinou G; Zamboglou N; Baltas D; Ferentinos K; Bon D; Tselis N
Brachytherapy; 2019; 18(6):829-834. PubMed ID: 31500935
[TBL] [Abstract][Full Text] [Related]
13. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
Lee LJ; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
[TBL] [Abstract][Full Text] [Related]
14. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers.
Onimaru R; Shirato H; Shimizu S; Kitamura K; Xu B; Fukumoto S; Chang TC; Fujita K; Oita M; Miyasaka K; Nishimura M; Dosaka-Akita H
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):126-35. PubMed ID: 12694831
[TBL] [Abstract][Full Text] [Related]
15. Effect and toxicity of endoluminal high-dose-rate (HDR) brachytherapy in centrally located tumors of the upper respiratory tract.
Harms W; Schraube P; Becker H; Latz D; Herth F; Fritz P; Wannenmacher M
Strahlenther Onkol; 2000 Feb; 176(2):60-6. PubMed ID: 10697652
[TBL] [Abstract][Full Text] [Related]
16. Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
Eze C; Taugner J; Roengvoraphoj O; Schmidt-Hegemann NS; Käsmann L; Wijaya C; Belka C; Manapov F
Radiat Oncol; 2019 Sep; 14(1):163. PubMed ID: 31484542
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of CT-guided high-dose-rate interstitial brachytherapy in primary and secondary malignancies of the pancreas.
Omari J; Heinze C; Wilck A; Hass P; Seidensticker M; Seidensticker R; Mohnike K; Ricke J; Pech M; Powerski M
Eur J Radiol; 2019 Mar; 112():22-27. PubMed ID: 30777214
[TBL] [Abstract][Full Text] [Related]
18. Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.
Kauffmann G; Wu T; Al-Hallaq H; Hasan Y
Brachytherapy; 2017; 16(1):141-146. PubMed ID: 27866953
[TBL] [Abstract][Full Text] [Related]
19. A Novel Form of Breast Intraoperative Radiation Therapy With CT-Guided High-Dose-Rate Brachytherapy: Results of a Prospective Phase 1 Clinical Trial.
Showalter SL; Petroni G; Trifiletti DM; Libby B; Schroen AT; Brenin DR; Dalal P; Smolkin M; Reardon KA; Showalter TN
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):46-54. PubMed ID: 27511846
[TBL] [Abstract][Full Text] [Related]
20. [Percutaneous CT-guided high-dose brachytherapy (CT-HDRBT) ablation of primary and metastatic lung tumors in nonsurgical candidates].
Collettini F; Schnapauff D; Poellinger A; Denecke T; Banzer J; Golenia MJ; Wust P; Gebauer B
Rofo; 2012 Apr; 184(4):316-23. PubMed ID: 22297915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
